BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 31784801)

  • 21. Serum lactate dehydrogenase predicts brain metastasis and survival in limited-stage small cell lung cancer patients treated with thoracic radiotherapy and prophylactic cranial irradiation.
    Liu J; Wu D; Shen B; Chen M; Zhou X; Zhang P; Qiu G; Ji Y; Du X; Yang Y
    Strahlenther Onkol; 2022 Dec; 198(12):1094-1104. PubMed ID: 35857072
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sequential vs. concurrent chemoradiation for stage III non-small cell lung cancer: randomized phase III trial RTOG 9410.
    Curran WJ; Paulus R; Langer CJ; Komaki R; Lee JS; Hauser S; Movsas B; Wasserman T; Rosenthal SA; Gore E; Machtay M; Sause W; Cox JD
    J Natl Cancer Inst; 2011 Oct; 103(19):1452-60. PubMed ID: 21903745
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Early compared with late radiotherapy in combined modality treatment for limited disease small-cell lung cancer: a London Lung Cancer Group multicenter randomized clinical trial and meta-analysis.
    Spiro SG; James LE; Rudd RM; Trask CW; Tobias JS; Snee M; Gilligan D; Murray PA; Ruiz de Elvira MC; O'Donnell KM; Gower NH; Harper PG; Hackshaw AK;
    J Clin Oncol; 2006 Aug; 24(24):3823-30. PubMed ID: 16921033
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Optimal timing of thoracic radiotherapy in limited stage small cell lung cancer (SCLC) with daily fractionation: A brief report.
    Hasan S; White R; Renz P; Abel S; Otaibi Z; Monga D; Colonias A; Wegner RE
    Radiother Oncol; 2019 Mar; 132():23-26. PubMed ID: 30825965
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metastatic location of extensive stage small-cell lung cancer: implications for thoracic radiation.
    Zhang H; Deng L; Wang X; Wang D; Teng F; Yu J
    J Cancer Res Clin Oncol; 2019 Oct; 145(10):2605-2612. PubMed ID: 31410604
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Thoracic Radiotherapy for Extensive Stage Small-Cell Lung Cancer: A Meta-Analysis.
    Palma DA; Warner A; Louie AV; Senan S; Slotman B; Rodrigues GB
    Clin Lung Cancer; 2016 Jul; 17(4):239-44. PubMed ID: 26498503
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phase 2 study of accelerated hypofractionated thoracic radiation therapy and concurrent chemotherapy in patients with limited-stage small-cell lung cancer.
    Xia B; Hong LZ; Cai XW; Zhu ZF; Liu Q; Zhao KL; Fan M; Mao JF; Yang HJ; Wu KL; Fu XL
    Int J Radiat Oncol Biol Phys; 2015 Mar; 91(3):517-23. PubMed ID: 25481679
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical Outcomes Following Stereotactic Body Radiation Therapy (SBRT) for Stage I Medically Inoperable Small Cell Lung Carcinoma: A Multi-Institutional Analysis From the RSSearch Patient Registry.
    Singh R; Ansinelli H; Sharma D; Jenkins J; Davis J; Vargo JA; Sharma S
    Am J Clin Oncol; 2019 Jul; 42(7):602-606. PubMed ID: 31232723
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Efficacy of chemotherapy combined hyperfractionated accelerated radiotherapy on limited small cell lung cancer].
    Hu X; Bao Y; Chen YY; Gao JM; Wang WH; Liu Y; He H; Sun ZW; Poudel S; Wang Y; Zhuang TT; Zhang L; Chen M
    Ai Zheng; 2008 Oct; 27(10):1088-93. PubMed ID: 18851790
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Thoracic irradiation in 3weeks for limited-stage small cell lung cancer: Is twice a day fractionation really needed?
    Turgeon GA; Souhami L; Kopek N; Hirsh V; Ofiara L; Faria SL
    Cancer Radiother; 2017 Apr; 21(2):89-98. PubMed ID: 28325618
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Can consolidative thoracic radiotherapy improve outcomes in extensive-disease small cell lung cancer after chemotherapy with complete/near-complete responders?
    Kirakli EK; Yilmaz H; Akcay C; Komurcuoglu B; Yilmaz U
    J Cancer Res Ther; 2020; 16(4):752-756. PubMed ID: 32930114
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Timing of thoracic radiotherapy in the treatment of extensive-stage small-cell lung cancer: important or not?
    Luo J; Xu L; Zhao L; Cao Y; Pang Q; Wang J; Yuan Z; Wang P
    Radiat Oncol; 2017 Feb; 12(1):42. PubMed ID: 28245874
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Thoracic radiotherapy (TRT) improved survival in both oligo- and polymetastatic extensive stage small cell lung cancer.
    Xu LM; Cheng C; Kang M; Luo J; Gong LL; Pang QS; Wang J; Yuan ZY; Zhao LJ; Wang P
    Sci Rep; 2017 Aug; 7(1):9255. PubMed ID: 28835666
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 70 Gy thoracic radiotherapy is feasible concurrent with chemotherapy for limited-stage small-cell lung cancer: analysis of Cancer and Leukemia Group B study 39808.
    Bogart JA; Herndon JE; Lyss AP; Watson D; Miller AA; Lee ME; Turrisi AT; Green MR;
    Int J Radiat Oncol Biol Phys; 2004 Jun; 59(2):460-8. PubMed ID: 15145163
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Thoracic radiation therapy improves the prognosis for patients with extensive stage small-cell lung cancer].
    Zhu H; Zhou ZM; Feng QF; Ou GF; Liang J; Zhang XR; Zhang HX; Chen DF; Xiao ZF; Wang LH
    Zhonghua Zhong Liu Za Zhi; 2011 Feb; 33(2):142-6. PubMed ID: 21575486
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cost-Effectiveness of Thoracic Radiation Therapy for Extensive-Stage Small Cell Lung Cancer Using Evidence From the Chest Radiotherapy Extensive-Stage Small Cell Lung Cancer Trial (CREST).
    Patrice GI; Lester-Coll NH; Yu JB; Amdahl J; Delea TE; Patrice SJ
    Int J Radiat Oncol Biol Phys; 2018 Jan; 100(1):97-106. PubMed ID: 29029885
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A phase II study of concurrent carboplatin and paclitaxel and thoracic radiotherapy for completely resected stage II and IIIA non-small cell lung cancer.
    Feigenberg SJ; Hanlon AL; Langer C; Goldberg M; Nicolaou N; Millenson M; Coia LR; Lanciano R; Movsas B
    J Thorac Oncol; 2007 Apr; 2(4):287-92. PubMed ID: 17409799
    [TBL] [Abstract][Full Text] [Related]  

  • 38. No survival benefit with early incorporation of thoracic radiotherapy using daily fractionation in patients with limited-stage small cell lung cancer undergoing chemoradiotherapy in the modern era: A systematic review and meta-analysis.
    Kim BH; Song C; Kim HJ
    Radiother Oncol; 2023 Jul; 184():109696. PubMed ID: 37150449
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Which patients with ES-SCLC are most likely to benefit from more aggressive radiotherapy: A secondary analysis of the Phase III CREST trial.
    Slotman BJ; Faivre-Finn C; van Tinteren H; Keijser A; Praag J; Knegjens J; Hatton M; van Dam I; van der Leest A; Reymen B; Stigt J; Haslett K; Tripathi D; Smit EF; Senan S
    Lung Cancer; 2017 Jun; 108():150-153. PubMed ID: 28625628
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Factors associated with severe acute esophagitis from hyperfractionated radiotherapy with concurrent chemotherapy for limited-stage small-cell lung cancer.
    Watkins JM; Wahlquist AE; Shirai K; Garrett-Mayer E; Aguero EG; Fortney JA; Sherman CA; Sharma AK
    Int J Radiat Oncol Biol Phys; 2009 Jul; 74(4):1108-13. PubMed ID: 19084345
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.